Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
47,139,902
-
Share change
-
-3,110,982
-
Total reported value
-
$773,715,370
-
Put/Call ratio
-
82%
-
Price per share
-
$16.41
-
Number of holders
-
148
-
Value change
-
-$64,868,300
-
Number of buys
-
74
-
Number of sells
-
58
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q1 2021
As of 31 Mar 2021 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,139,902 shares of stock of the company.
Largest 10 holders included Opaleye Management Inc., BlackRock Inc., SUMMER ROAD LLC, VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, STATE STREET CORP, EMERALD MUTUAL FUND ADVISERS TRUST, EMERALD ADVISERS, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 149 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.